WO-A1-2005/037287 (B1)

WO-A2-2005/028443 (B2)

WO-A2-2006/116514 (B1)

WO-A2-2007/130438 (B1)

WO-A2-2008/089087 (B1)

WO-A2-2011/002857 (B1)

"Chapters 25, 27 and 28" In: Aulton ME: 2001, Churchill Livingstone ISBN: 9780443055171 pages 364-378, 397-448, (B2)

"Film coating of oral and solid dosage forms + Tablet Manufacture" In: James Swarbrick: "ENCYCLOPEDIA OF PHARMACEUTICAL TECHNOLOGY Third Ed.", 1 January 2007 (2007-01-01) ISBN: 978-0-8493-9399-0 vol. 3 and 6, pages Cover-V, 1729-1747, 3653-3672, (B2)

A. REID et al.: "Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu", Eur. J. Cancer, vol. 43, 2007, pages 481-489, DOI: 10.1016/j.ejca.2006.11.007 (B2)

Avicel® PH-101, https://www.sigmaaldrich.com/catalog (B2)

BEDARD PHILIPPE L et al.: "Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancer", CURRENT CANCER DRUG TARGETS MAR 2009 LNKD- PUBMED:19275756, vol. 9, no. 2, March 2009 (2009-03), pages 148-162, (B2)

ClinicalTrials.gov. entry for clinical trial of D16 (NCT00397046) (B2)

Ehab Hamed, Derek Moe, Raj Khankari, John Hontz: "4. Binders and Solvents" In: Dilip M. Parikh: "Handbook of Pharmaceutical Granulation Technology, Second Edition", 2005, Taylor & Francis ISBN: 9780824726478 vol. 198, pages 109-128, (B2)

Expert Declaration of Prof. PhD. Patrick J. Sinko (B2)

HEYMACH J V et al.: "Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer", CLINICAL CANCER RESEARCH, vol. 12, no. 14, 15 July 2006 (2006-07-15) , pages 4441 s-4445s, US ISSN: 1078-0432 (B2)

Handbook of Pharmaceutical Manufacturing Formulations, Compressed Solid Products, Vol.1, 2nd Ed., Niazi, 2009 (B2)

Ito et al. Jpn. J. Clin. Oncol. 2012, 42(4), 278-286 (B2)

Kadam et al. Asian J. Pharm. Clin. Res. 2009, 2, 39-43 (B2)

Kibbe AH: "Povidone" In: Raymond C Rowe, Paul J Sheskey, Marian E Quinn: "Handbook Of Pharmaceutical Excipients 6th Edition", 2009 ISBN: 978 0 85369 792 3 pages 581-585, (B2)

Planinsek, O. ; Pisek, R. ; Trojak, A. ; Srcic, S.: "The utilization of surface free-energy parameters for the selection of a suitable binder in fluidized bed granulation", INTERNATIONAL JOURNAL OF PHARMACEUTICS,, vol. 207, no. 1-2, 10 October 2000 (2000-10-10), pages 77-88, ELSEVIER, NL ISSN: 0378-5173 (B2)

WIDAKOWICH C et al.: "HER-2 positive breast cancer: What else beyond trastuzumab- based therapy?", ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, vol. 8, no. 5, 1 June 2008 (2008-06-01), pages 488-496, NL (B2)

WISSNER ALLAN et al.: "The development of HKI-272 and related compounds for the treatment of cancer", ARCHIV DER PHARMAZIE AUG 2008 LNKD- PUBMED:18493974, vol. 341, no. 8, August 2008 (2008-08), pages 465-47 7, (B2)

WO-A1-2008/093878 (B1)